EBC Statement on the Critical Medicines Act
On March 11, the European Commission presented the much-anticipated Critical Medicines Act, a proposal aimed at strengthening the resilience and autonomy of the EU’s pharmaceutical supply chain. The European Brain Council (EBC) welcomes this initiative as an important step toward a stronger, more innovative, and competitive Health Union, particularly in light of increased geopolitical [...]